Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/SANTHERA-PHARMACEUTICALS--195471/actualite/Santhera-cede-une-licence-sur-le-Raxone-pour-jusqu-a-105-millions-de-francs-28643430/?utm_source=whatsapp&utm_medium=social&utm_campaign=share